CBIO FY 2016 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$327M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18,500-99.9% YoY

Gross Profit

$18,500100.0% margin

Operating Income

-$32M-172505.3% margin

Net Income

-$32M-171945.1% margin

EPS (Diluted)

$-1.50

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$42M

Total Liabilities

$7M

Stockholders' Equity

$35M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18,500	$20M	-99.9%
Gross Profit	$18,500	$20M	-99.9%
Operating Income	-$32M	-$13M	-149.6%
Net Income	-$32M	-$13M	-149.1%